dihydrotetrabenazine has been researched along with Disease Models, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gjedde, A; Jakobsen, S; Landau, AM; Phan, JA; Romero-Ramos, M; Stokholm, K; Vang, K; Zareba-Paslawska, J | 1 |
| Brown, CA; Flores, HP; Karimi, M; Loftin, SK; Moerlein, SM; Perlmutter, JS; Tian, L; Videen, TO | 1 |
| Dinelle, K; Doudet, DJ; Flores, J; Jing, Y; Mackey, S | 1 |
| Brown, CA; Flores, H; Karimi, MK; Loftin, SK; Moerlein, SM; Perlmutter, JS; Su, Y; Tabbal, SD; Tian, L | 1 |
| Blesa, J; Cavada, C; Hornykiewicz, O; Obeso, JA; Pifl, C; Rajput, A; Rajput, AH; Reither, H | 1 |
| Collantes, M; Delgado, M; Ecay, M; Gago, B; Iglesias, E; Juri, C; Marín, C; Molinet-Dronda, F; Obeso, JA; Peñuelas, I; Prieto, E; Quiroga-Varela, A | 1 |
| Arponen, E; Asser, A; Bergquist, J; Eltermaa, M; Grönroos, T; Haaparanta-Solin, M; Kõks, S; Lindmäe, H; Nairismägi, J; Piip, P; Rinne, JO; Sauk, M; Snellman, A; Soomets, U; Taba, P | 1 |
| Alexander, M; Burton, NC; Griswold, M; Guilarte, TR; McGlothan, JL; Pham, L; Schneider, JS; Syversen, T; Verina, T; Wong, DF; Zhou, Y | 1 |
| Arbizu, J; Blesa, J; Cavada, C; Collantes, M; García-García, D; Iglesias, E; Juri, C; Martí-Climent, J; Obeso, JA; Peñuelas, I; Prieto, E; Richter, JA; Rodríguez-Oroz, MC; Zubieta, JL | 1 |
| Rehavi, M; Simchon, Y; Weizman, A | 1 |
| Rehavi, M; Schwartz, K; Weizman, A; Yadid, G | 1 |
| Goland, R; Hardy, M; Harris, PE; Kilbourn, M; Leibel, R; Maffei, A; Mann, JJ; Raffo, A; Saxena, C; Simpson, N; Souza, F; Van Heertum, R | 1 |
| Adams, RJ; Alexander, M; Brasić, JR; Burton, NC; Chen, MK; Guilarte, TR; Kumar, A; Kuwabara, H; McGlothan, JL; Verina, T; Wong, DF; Zhou, Y | 1 |
13 other study(ies) available for dihydrotetrabenazine and Disease Models, Animal
| Article | Year |
|---|---|
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Carbon Radioisotopes; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Parkinson Disease; Positron-Emission Tomography; Presynaptic Terminals; Rats; Rats, Transgenic; Substantia Nigra; Synapses; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |
Validation of nigrostriatal positron emission tomography measures: critical limits.
Topics: Animals; Cocaine; Corpus Striatum; Disease Models, Animal; Fluorodeoxyglucose F18; Macaca mulatta; Magnetic Resonance Imaging; Male; MPTP Poisoning; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Reproducibility of Results; Substantia Nigra; Tetrabenazine | 2013 |
Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.
Topics: Acetylcysteine; Analysis of Variance; Animals; Carbon Isotopes; Cell Count; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hindlimb; Locomotion; Movement Disorders; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tetrabenazine; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.
Topics: Animals; Carbon Isotopes; Disease Models, Animal; Fluorodeoxyglucose F18; Macaca mulatta; Magnetic Resonance Imaging; Male; Mesencephalon; MPTP Poisoning; Neurons; Positron-Emission Tomography; Substantia Nigra; Tetrabenazine | 2013 |
Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
Topics: Aged; Aged, 80 and over; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Female; Homovanillic Acid; Humans; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Monoamine Transport Proteins | 2014 |
Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
Topics: Adrenergic Agents; Animals; Apomorphine; Brain; Carbon Radioisotopes; Disease Models, Animal; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Functional Laterality; Longitudinal Studies; Magnetic Resonance Imaging; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tetrabenazine | 2015 |
Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese.
Topics: Animals; Autoradiography; Biomechanical Phenomena; Carbon Radioisotopes; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Gait; Illicit Drugs; Injections, Intraperitoneal; Male; Manganese; Mice, Inbred C57BL; Motor Activity; Positron-Emission Tomography; Propiophenones; Psychotropic Drugs; Radiopharmaceuticals; Random Allocation; Substance-Related Disorders; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2016 |
Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.
Topics: Amphetamine; Animals; Cocaine; Corpus Striatum; Cyclohexanols; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Image Processing, Computer-Assisted; Macaca fascicularis; Male; Manganese; Parkinsonian Disorders; Positron-Emission Tomography; Substantia Nigra; Synaptic Transmission; Tetrabenazine; Tyrosine 3-Monooxygenase | 2008 |
Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
Topics: Animals; Brain Mapping; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Dyskinesias; Female; Macaca fascicularis; Male; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Severity of Illness Index; Signal Processing, Computer-Assisted; Tetrabenazine | 2010 |
The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Binding Sites; Brain; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Methylphenidate; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine; Synaptosomes; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2010 |
Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression.
Topics: Animals; Depression; Disease Models, Animal; Limbic System; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.
Topics: Animals; Blood Glucose; Carbon Radioisotopes; Diabetes Mellitus, Type 1; Disease Models, Animal; Humans; Insulin; Insulin-Secreting Cells; Male; Papio; Positron-Emission Tomography; Radioligand Assay; Rats; Rats, Inbred BB; Rats, Sprague-Dawley; Tetrabenazine; Tissue Distribution; Vesicular Monoamine Transport Proteins | 2006 |
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease.
Topics: Animals; Autoradiography; Brain; Carbon Isotopes; Carrier Proteins; Cocaine; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Glial Fibrillary Acidic Protein; Isoquinolines; Male; Neurons; Papio anubis; Parkinsonian Disorders; Positron-Emission Tomography; Raclopride; Tetrabenazine; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2008 |